Evaluating the Minimal Clinically Important Difference of the King'S Sarcoidosis Questionnaire (KSQ) in a Multi-Center, Prospective TrialR.P. Baughman, SS Birring, Daniel A. Culver et al.|Unknown|2020Cited by 1
Safety and Efficacy ATYR1923, a Novel Immunomodulator for Pulmonary Sarcoidosis: Results of a Phase 1b/2a Randomized Placebo-Controlled TrialPeter H. S. Sporn, R.P. Baughman, D.A. Culver et al.|Unknown|2022Cited by 1
Low Prevalence of Cardiac Sarcoidosis Using Routine and Enhanced Screening Strategies in Unselected Sarcoidosis Patients: Preliminary Baseline Data from the Foundation for Sarcoidosis Research Clinical Studies Network Screening TrialD.A. Culver, Lisa Maier, M.L. Ribeiro Neto et al.|Unknown|2022Cited by 0